SCHEMBL11945073

SCHEMBL11945073

CCOCCOc1c(N2CCN(S(C)(=O)=O)CC2)cnn(-c2cccc(C(F)(F)F)c2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ DCTPP1 Q9H773 1/20 0.46
▸ NPBWR1 P48145 1/20 0.45
▸ MCHR1 Q99705 1/20 0.45
▸ MAPT P10636 5/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ POLB P06746 3/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ NCOA2 Q15596 1/20 0.41
▸ NCOA1 Q15788 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ LMNA P02545 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ GBA1 P04062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11943952 0.91 MAPT (0.44) ALDH1A1NPBWR1MCHR1MAPTTP53
SCHEMBL11945077 0.90 ALDH1A1 (0.49) ALDH1A1DCTPP1MAPTPOLBCYP3A4
SCHEMBL11945071 0.88 ALDH1A1 (0.54) ALDH1A1DCTPP1NPBWR1MCHR1MAPT
SCHEMBL11943967 0.87 ALDH1A1 (0.48) ALDH1A1DCTPP1NPBWR1MAPTPOLB
SCHEMBL11943891 0.87 ALDH1A1 (0.61) ALDH1A1DCTPP1MAPTPOLBCYP3A4
SCHEMBL11943836 0.86 ALDH1A1 (0.47) ALDH1A1NPBWR1MCHR1MAPTTP53
SCHEMBL11943838 0.86 ALDH1A1 (0.58) ALDH1A1DCTPP1NPBWR1MCHR1MAPT
SCHEMBL11943833 0.85 SMO (0.48) ALDH1A1NPBWR1MCHR1MAPTTP53
SCHEMBL11943814 0.85 NPBWR1 (0.47) ALDH1A1DCTPP1NPBWR1MCHR1MAPT
SCHEMBL11943849 0.84 ALDH1A1 (0.52) ALDH1A1DCTPP1NPBWR1MCHR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA ALDH1A1 2437/4885DCTPP1 625/4885NPBWR1 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback